ZURICH (Reuters) - Swiss drugmaker Roche said U.S. health regulators have granted a priority review of its Avastin drug when combined with chemotherapy to treat women with cervical cancer.
An approval by the U.S. Food and Drug Administration for treating advanced cervical cancer would open another large market for the medicine in patients for whom chemotherapy has been largely ineffective. About 4,000 women in the United States and 250,000 worldwide die each year from the disease.
18:38 Thunder's Enes Kanter returning to U.S. after being detained at a Romanian airport13
17:29 Trump, Saying He Is Treated ‘Unfairly,’ Signals a Fight52
05:05 Erdogan’s big meeting with Trump gets obscured by White House chaos29
23:20 Trump, Erdogan commit to cooperation despite tensions over Syrian militias25